1501 W. Beauregard
San Angelo, Texas 76901
Phone: (325) 658-7750
Fax: (325) 658-8381
Crisis: (800) 375-8965
or (325) 653-5933

Basic Information
Local ContentWhat is Autism?Historical & Contemporary Understandings of AutismSymptoms of Autism & Related DisordersDiagnosis of AutismAutism Interventions & Supportive ServicesAutism ResourcesMore InformationLatest News
Prenatal Vitamins Tied to Lower Autism Risk in Kids, Study FindsPrevalence of Autism Seems to Be Stabilizing in U.S. Children, TeensU.S. Autism Rates May Be StabilizingNeuroanatomic Abnormalities ID'd in Those at Risk for AutismMaternal Multivitamin Use Tied to Lower Risk of Child ASDResearchers Learn More About Gender's Role in Autism RiskGenetics a Cause of Autism in Most Cases: StudyCould Folic Acid Fight a Cause of Autism?Does Autism Risk Reside in Cells' Energy Engines?Therapy for Kids With Autism Pays Off for Moms, DadsCan Scans Predict Some Autism Cases?Guidelines Developed for Art Therapy for Children With ASDAntidepressants in Pregnancy Tied to Slight Increase in AutismCan a Spritz of 'Love Hormone' Help Kids With Autism?Why People With Autism Avoid Eye ContactWhen is Tourette Syndrome Actually Autism?Study Cites Top Reasons Young Autism Patients Are HospitalizedFever During Pregnancy Tied to Autism in StudySpecial Brain Scans May Predict Autism in High-Risk BabiesBaby Teeth Study Points to Links Between Autism, Lead LevelsCommunication Problems Not at Root of Tantrums in Kids With AutismNo Proof Special Diets, Supplements Work for AutismCould a Century-Old Drug Help Ease Autism Symptoms?Autism's 'Worryingly' High Suicide Rates Spur ConferenceSpecial Diets, Supplements for Autism Still a Question MarkProdromal Intervention Effective for Infants at Risk of AutismProgram Helps Young Adults With Autism Find JobsTreat Autism Even Before Symptoms Show?Tracking Devices May Ease Minds of Parents of Kids With AutismYoung Adults With Autism Need Help Managing Money: StudyFDA Warns Against Bogus Autism 'Cures'1 in 3 Teens With Autism Licensed to Drive, Study Finds'Video Feedback' Program Might Help Treat Autism in BabiesMuppet With Autism Makes Her 'Sesame Street' DebutParents of Kids With Autism May Sacrifice 'Couples Time'Teens With Autism More Likely to Land in ER, Study FindsHigher Risk of Death From Injury Among Individuals With AutismAutism Greatly Boosts Kids' Injury Risk, Especially for DrowningCould a Blood Test Spot Autism in Childhood?MRI Can Identify Early Signs of ASD in High-Risk InfantsExperimental Test Can Spot Autism in InfancyBrain Differences Hint at Why Autism Is More Common in MalesU.S. Legislation Boosted Access to Autism Services, With No Added Cost to FamiliesObstetric Complications Tied to Slightly Upped Risk for AutismMicrobiota Transfer Therapy Could Help Children With AutismFecal Transplant Shows Early Promise Against AutismGuideline Changes Have Asperger's Community on Edge
Questions and AnswersLinksBook Reviews
Related Topics

Childhood Mental Disorders and Illnesses

Could a Century-Old Drug Help Ease Autism Symptoms?

HealthDay News
by By Alan Mozes
HealthDay Reporter
Updated: May 26th 2017

new article illustration

FRIDAY, May 26, 2017 (HealthDay News) -- A drug first used in the early 1900s to treat sleeping sickness has shown promise in an early trial as a potential treatment for autism.

The study involved just 10 boys, aged 5 to 14, with autism. This was the first human trial to attempt to replicate encouraging results seen in work with mice, the researchers noted. The drug is called suramin.

"The main finding was that a single dose of suramin was safe and produced improvements in language, social interaction and restricted and/or repetitive behaviors in five children with ASD [autism spectrum disorder]," said study author Dr. Robert Naviaux. He is co-director of the Mitochondrial and Metabolic Disease Center at the University of California, San Diego's School of Medicine.

He added that no such improvements were observed among the five children not treated with suramin.

However, the gains from the one-dose treatment proved to be temporary, fading within a matter of weeks, the researchers said.

Naviaux stressed that the latest effort was just "a start." At the moment, suramin is not approved for any use in the United States, and much more follow-up research will be needed, he cautioned. The drug is used for sleeping sickness, which is caused by parasites.

Roughly 1 in every 68 children develops some form of autism, according to the U.S. Centers for Disease Control and Prevention.

Exactly what causes autism remains unclear. But this latest trial set out to test one specific theory known as the "cell danger hypothesis."

The theory suggests that at least some cases of autism arise when the body's normal reaction to stress and injury goes haywire.

In such a scenario, the usual healing process -- which involves the temporary halting of communication between cells -- ends up becoming permanent, causing cells to behave as if they're continually under assault. The theory suggests this dynamic might lead to autism, the researchers explained.

Suramin, however, has the ability to block a specific molecule known as ATP, which relentlessly triggers this abnormal healing process, the researchers said.

Essentially, explained Naviaux, "suramin is a molecular armistice therapy. It sends the message to the cell that the war is over."

Five of the 10 study patients were given one intravenous infusion of suramin, while the other five were treated with a placebo drug.

All the boys treated with suramin ended up showing significant -- and, in some cases, immediate -- improvements, with no serious side effects, researchers said.

The most notable changes involved improved socializing, communication and playing. Those in the suramin group also showed an increased ability to remain calm and focused, while displaying less repetitive behavior and better coping skills.

One parent said a son displayed more emotional range, improved eye contact, greater interest in socializing, and a new sense of calmness within hours following treatment, the researchers said.

And two children who had never spoken in their lives did so for the first time, within roughly one week after treatment, the researchers added.

Suramin also appeared to boost the ability to benefit from standard treatment, such as speech therapy and behavior therapy.

However, all the improvements from the one-dose treatment proved to be temporary, with gains ultimately fading over a matter of weeks.

"[But] we are cautiously optimistic," said Naviaux, while noting that it will be at least four to five years before follow-up research is complete. "The science," he said, "cannot be rushed."

The findings were published May 26 in the Annals of Clinical and Translational Neurology.

Dr. Matthew Lorber, a child and adolescent psychiatrist with Lenox Hill Hospital in New York City, reacted to the findings with caution.

"The improvement in the children studied was robust," he noted, "which is cause for hope, since we do not have any approved treatments for the root of autism.

"Unfortunately," Lorber added, "the study was so small -- only five children actually received the medication -- that we cannot come to any real conclusions."

The upshot, Lorber said, is that "until suramin is tested in a much larger group of people with autism, we cannot move ahead using it as a potential treatment. In addition, suramin in traditional doses can have serious side effects, and it is important that doctors do not start using it for children with autism because the data is scant, and we need much more scientific research."

HealthDay reached out to two advocacy groups, Autism Speaks and the Autism Society of America, but did not receive comment.

More information

There's more on autism at the U.S. National Institutes of Health.